GALWAY

戈尔韦

,

，

Ireland

爱尔兰

,

，

Dec. 2

12月2日

, 2025

，2025

/

/

PRNewswire

美通社

/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed™ systems. Following U.S. FDA clearance of the system earlier this year to enable integration with the Instinct sensor, the system is now shipping to customers across the U.S., marking a major milestone in diabetes technology and delivering a smart, seamless way to manage diabetes..

/ -- 全球医疗技术领导者美敦力（Medtronic，纽约证券交易所代码：MDT）今天宣布，在美国全面推出与雅培公司制造的Instinct传感器集成的MiniMed™ 780G系统，该传感器专为MiniMed™ 系统设计。在今年早些时候获得美国FDA对该系统的批准后，该系统现已开始向全美客户发货，标志着糖尿病技术领域的一个重要里程碑，并提供了一种智能、无缝的糖尿病管理方式。

The Instinct sensor is based on Abbott's most advanced CGM technology, featuring the world's smallest

Instinct传感器基于Abbott最先进的CGM技术，具有世界上最小的尺寸。

1,2

1,2

, thinnest

，最薄的

1

1

, most discreet

，非常谨慎

2

2

sensor and offers a wear time of up to 15 days. When paired with the MiniMed™ 780G system, the Instinct sensor provides real-time glucose readings which the system uses to automate insulin adjustments every five minutes, helping people with diabetes spend less time managing their condition and more time living their life..

传感器，最长可佩戴15天。当与MiniMed™ 780G系统配合使用时，Instinct传感器提供实时的葡萄糖读数，系统每五分钟利用这些读数自动调整胰岛素，帮助糖尿病患者减少管理病情的时间，更多地享受生活。

'Bringing together the Instinct sensor, made by Abbott, with the excellent algorithm of the MiniMed™ 780G system creates an extremely effective combination. With the MiniMed™ 780G system, my patients have seen improved time in range and now with the Instinct sensor it's a seamless experience,' said Dr.

“将雅培生产的Instinct传感器与MiniMed™ 780G系统的优秀算法结合在一起，创造了一个极为有效的组合。通过MiniMed™ 780G系统，我的患者在目标范围内的时间得到了改善，而现在有了Instinct传感器，体验更加无缝。”博士说道。

.

。

Steve Edelman

史蒂夫·埃德尔曼

, a person living with type 1 diabetes and founder and director of Taking Control of Your Diabetes 501c3 (

，一位患有1型糖尿病的人，同时也是掌控你的糖尿病501c3组织的创始人和董事（

TCOYD.org

TCOYD.org

). 'Feedback from the early customer pilot program has been very positive and matches what my colleagues and I are seeing in our clinics. I'm thrilled that the Instinct sensor is now available so that more people living with type 1 diabetes will get access to this life-changing technology improving their day-to-day experience dealing with this difficult condition.'.

“早期客户试点项目的反馈非常积极，与我和我的同事在诊所中看到的情况相符。令我感到兴奋的是，Instinct传感器现在已经上市，这样更多患有1型糖尿病的人将获得这项改变生活、改善他们应对这一棘手疾病日常体验的技术。”

The launch of the Instinct sensor expands Medtronic's sensor portfolio, offering more choice alongside the recently launched Simplera Sync™ sensor and the Guardian™ 4 sensor—all part of a growing ecosystem designed to make diabetes care easier and more personalized.

Instinct传感器的推出扩大了美敦力的传感器产品组合，与最近推出的Simplera Sync™传感器和Guardian™ 4传感器一起为用户提供更多选择——所有这些都属于一个不断发展的生态系统，旨在使糖尿病护理更轻松、更个性化。

'This milestone marks an important next step in our work to bring the proven clinical outcomes of our MiniMed™ 780G system to more people living with diabetes,' said Que Dallara, EVP and president of Medtronic Diabetes. 'With this launch, we're expanding a smart dosing ecosystem built for choice, so every person can find a solution that fits their life.

“这一里程碑标志着我们在将MiniMed™ 780G系统的临床效果带给更多糖尿病患者的工作中迈出了重要的下一步，”美敦力糖尿病业务的执行副总裁兼总裁Que Dallara表示，“通过此次发布，我们正在扩展一个为选择而构建的智能给药生态系统，让每个人都能找到适合其生活的解决方案。”

We exist to make life with diabetes easier and more predictable, so people living with diabetes can enjoy greater freedom and better health every day. Our goal is to deliver confidence and peace of mind, so everyone—including loved ones—can live boldly without compromise.'.

我们的使命是让糖尿病患者的生活更加轻松、更加可预测，从而让他们每天都能享受更多的自由和更好的健康。我们的目标是给予信心与安心，让每个人——包括亲人——都能无妥协地勇敢生活。

Learn more

了解更多

about the MiniMed™ 780G system paired with Instinct.

关于与Instinct配对的MiniMed™ 780G系统。

Frequently Asked Questions

常见问题解答

Q: What is the MiniMed™ 780G system?

问：MiniMed™ 780G 系统是什么？

A: It's Medtronic's most advanced automated insulin delivery system that automatically adjusts insulin every five minutes based on real-time glucose readings, helping reduce highs and lows and making diabetes management easier and less time-consuming.*

A: 这是美敦力最先进的自动胰岛素输送系统，该系统每五分钟根据实时血糖读数自动调整胰岛素，有助于减少高低血糖波动，使糖尿病管理更轻松、更省时。*

Q: What makes the Instinct sensor different?

问：是什么让Instinct传感器与众不同？

A: Instinct, made by Abbott, offers up to 15 days of wear, fewer insertions, and a slim, discreet design. It's the world's smallest and thinnest integrated CGM, providing comfort and convenience without compromising accuracy.

A: Abbott制造的Instinct提供长达15天的佩戴时间，减少插入次数，并具有纤薄、隐蔽的设计。它是世界上最小、最薄的集成式CGM，提供舒适和便利，同时不牺牲准确性。

About the Diabetes Business at Medtronic

关于美敦力的糖尿病业务

Medtronic Diabetes is on a mission to make diabetes more predictable, so everyone can embrace life to the fullest with the most advanced diabetes technology and always-on support when and how they need it. We've pioneered first-of-its-kind innovations for over 40 years and are committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront..

美敦力糖尿病事业部致力于让糖尿病变得更可预测，使每个人都能通过最先进的糖尿病技术和随时随地的支持，充分享受生活。四十多年来，我们率先推出了多项首创的创新技术，并承诺通过下一代传感器（CGM）、智能给药系统以及数据科学和人工智能的力量，设计糖尿病管理的未来，同时始终将客户体验放在首位。

About Medtronic

美敦力公司简介

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in

大胆思考。更大胆的行动。我们是美敦力。美敦力公司，总部位于

Galway

戈尔韦

,

，

Ireland

爱尔兰

, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

是全球领先的医疗技术公司，大胆攻克人类面临的最棘手健康问题，寻找并提供解决方案。我们的使命——减轻病痛、恢复健康、延长生命——团结了遍布150多个国家的95,000多名充满热情的员工。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们多样化的知识、无尽的好奇心和帮助所有需要帮助的人的愿望，我们提供了创新的技术，每秒、每小时、每一天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit .

随着我们推动以洞察力为导向的护理、以人为本的体验以及为我们的世界带来更好的结果，请对我们有更多期待。在我们所做的一切中，我们正在创造非凡。欲了解有关美敦力（纽约证券交易所代码：MDT）的更多信息，请访问。

www.Medtronic.com

www.美敦力.com

and follow on

并关注

LinkedIn

领英

.

。

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

任何前瞻性陈述均受风险和不确定性的影响，例如美敦力公司向证券交易委员会提交的定期报告中所述的风险和不确定性。实际结果可能与预期结果有重大差异。

Among patient-applied sensors.

在患者应用的传感器中。

Data on file. Abbott Diabetes Care, Inc.

数据存档。雅培糖尿病护理公司。

*Refers to SmartGuard™ technology. Individual results may vary.

*指 SmartGuard™ 技术。个人结果可能有所不同。

Medtronic is a sponsorship partner of TCOYD. Dr.

美敦力是TCOYD的赞助合作伙伴。

Steve Edelman

史蒂夫·埃德尔曼

was not compensated for his quote.

未因他的报价获得补偿。

Contacts:

联系人：

Ashley Patterson

艾希礼·帕特森

Global Communications

全球通讯

+1 (818) 576-3025

+1 (818) 576-3025

Ryan Weispfenning

瑞安·魏斯芬宁

Investor Relations

投资者关系

+1 (763) 505-4626

+1 (763) 505-4626

SOURCE Medtronic plc

来源：美敦力公司